News for Fuji Pharma Co., Ltd. (4554.T)

**media[577816]**

**media[577814]**

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as ”œDr. Reddy's”) a

**media[569574]**

**media[569571,569572]**

**media[560208]**

**media[560204]**

**media[546506,546507]**

**media[546504,546505]**

**media[546502,546503]**

**media[524901,524902]**

**media[524895,524896]**

**media[524894]**

REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech ( ALVO), a global biotech company specializing in the development and manu

Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024

Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI)Inclusion criteria include minimum market capitalization and daily trading volume

**media[465426]**

Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia ® and Xgeva ®